Methods and compositions using stearoyl-CoA desaturase to identify triglyceride reducing therapeutic agents
US6987001B2 · kind B2 · utility
3Cited by
2References
11Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Feb 23, 2001 |
| Grant date | Jan 17, 2006 |
| Priority date | — |
| Expiry date | Jun 7, 2022 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2333/90245
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The use of screening assays based on the role of human stearoyl-CoA desaturase-1 (“hSCD1”) in human diseases, disorders or conditions relating to serum levels of triglyceride, VLDL, HDL, LDL, total cholesterol, or production of secretions from mucous membranes, monounsaturated fatty acids, wax esters, and the like, is disclosed. Also disclosed are conventions useful in the prevention and/or treatment of such diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.